Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents

MLA

Anne Sophie Voisin-Chiret, et al. “Tau Protein Aggregation in Alzheimer’s Disease: An Attractive Target for the Development of Novel Therapeutic Agents.” European Journal of Medicinal Chemistry, vol. 139, July 2017. EBSCOhost, https://doi.org/10.1016/j.ejmech.2017.07.070⟩.

APA

Anne Sophie Voisin-Chiret, Sylvain Rault, & Marie Jouanne. (2017). Tau protein aggregation in Alzheimer’s disease: An attractive target for the development of novel therapeutic agents. European Journal of Medicinal Chemistry, 139. https://doi.org/10.1016/j.ejmech.2017.07.070⟩

Chicago

Anne Sophie Voisin-Chiret, Sylvain Rault, and Marie Jouanne. 2017. “Tau Protein Aggregation in Alzheimer’s Disease: An Attractive Target for the Development of Novel Therapeutic Agents.” European Journal of Medicinal Chemistry 139 (July). doi:10.1016/j.ejmech.2017.07.070⟩.